DIABETIC NEPHROPATHIES
Clinical trials for DIABETIC NEPHROPATHIES explained in plain language.
Never miss a new study
Get alerted when new DIABETIC NEPHROPATHIES trials appear
Sign up with your email to follow new studies for DIABETIC NEPHROPATHIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common cholesterol pill save sight in type 1 diabetes?
Disease control OngoingThis study tests whether a daily pill called fenofibrate can slow or prevent worsening eye disease (diabetic retinopathy) in adults with type 1 diabetes. About 412 participants with early eye damage are taking either the drug or a placebo for several years. The goal is to see if …
Matched conditions: DIABETIC NEPHROPATHIES
Phase: PHASE3 • Sponsor: University of Sydney • Aim: Disease control
Last updated May 17, 2026 10:40 UTC
-
Can a strawberry compound fight kidney disease inflammation?
Disease control TerminatedThis study tests whether a natural compound called fisetin can reduce inflammation and improve stem cell function in 30 adults with advanced chronic kidney disease, including those with diabetes. Participants will take fisetin or a placebo for 14 days, and researchers will measur…
Matched conditions: DIABETIC NEPHROPATHIES
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 17, 2026 10:39 UTC
-
Could a cheap drug shield kidneys from diabetes damage?
Prevention OngoingThis study tests whether fenofibrate, a drug typically used to lower blood fats, can prevent kidney function loss in people with type 1 diabetes who are at high risk of kidney failure. Forty participants will receive either fenofibrate or a placebo for 18 months, and their kidney…
Matched conditions: DIABETIC NEPHROPATHIES
Phase: PHASE2 • Sponsor: Alessandro Doria • Aim: Prevention
Last updated May 17, 2026 10:26 UTC
-
Massive diabetes biobank aims to unlock secrets of kidney and heart disease
Knowledge-focused OngoingThis study is creating a large biobank of health information and blood samples from 48,000 people with diabetes in Hong Kong. Researchers will analyze genes and other markers to better predict who is at risk for serious complications like kidney failure, heart disease, and stroke…
Matched conditions: DIABETIC NEPHROPATHIES
Sponsor: Chinese University of Hong Kong • Aim: Knowledge-focused
Last updated May 12, 2026 13:42 UTC